Tumor microenvironment-adjusted prognostic implications of the KRAS mutation subtype in patients with stage III colorectal cancer treated with adjuvant FOLFOX | Scientific Reports
Frontiers | New Horizons in KRAS-Mutant Lung Cancer: Dawn After Darkness
Clinical characteristics and prognostic value of the KRAS mutation in Chinese colorectal cancer patients - Ye Yuan, Yingting Liu, Ye Wu, Junling Zhang, Chunti Shen, Feng Zhang, Changping Wu, Wenwei Hu, 2021
Immune modulatory effects of oncogenic KRAS in cancer | Nature Communications
Prognostic role of KRAS mutations in Sardinian patients with colorectal carcinoma
Clinical and prognostic features of patients with detailed RAS/BRAF-mutant colorectal cancer in Japan | BMC Cancer | Full Text
KRAS Mutation in Colon Cancer: A Marker of Resistance to EGFR-I Therapy | Annals of Surgical Oncology
Frontiers | Targeting KRAS Mutant in Non-Small Cell Lung Cancer: Novel Insights Into Therapeutic Strategies
KRAS Codon 12 Mutation is Associated with More Aggressive Invasiveness | OTT
Can KRAS Positive Colorectal and Lung Cancer Finally be Targeted? - CancerConnect
RAS mutations: impact on treatment outcome | Colorectal Cancer
KRAS mutation: from undruggable to druggable in cancer | Signal Transduction and Targeted Therapy
Microsatellite Instability and KRAS Mutation in Stage IV Colorectal Cancer: Prevalence, Geographic Discrepancies, and Outcomes From the National Cancer Database in: Journal of the National Comprehensive Cancer Network Volume 19 Issue 3 (2021)
Frontiers | Prognostic and therapeutic impact of the KRAS G12C mutation in colorectal cancer
The current understanding on the impact of KRAS on colorectal cancer - ScienceDirect
,0.jpg "Progress towards individualized treatment of colorectal cancer UAB Barcelona")
Progress towards individualized treatment of colorectal cancer UAB Barcelona
Life | Free Full-Text | Integrated Decision-Making in the Treatment of Colon-Rectal Cancer: The Case of KRAS-Mutated Tumors
Role of oncogenic KRAS in the prognosis, diagnosis and treatment of colorectal cancer | Molecular Cancer | Full Text
Molecular profile of KRAS G12C-mutant colorectal and non-small-cell lung cancer | BMC Cancer | Full Text
KRAS mutation: from undruggable to druggable in cancer | Signal Transduction and Targeted Therapy
The Prognostic Impact of KRAS G12C Mutation in Patients with Metastatic Colorectal Cancer: A Multicenter Retrospective Observational Study - Chida - 2021 - The Oncologist - Wiley Online Library
IJMS | Free Full-Text | Gene Therapy Targeting p53 and KRAS for Colorectal Cancer Treatment: A Myth or the Way Forward?
Gene mutation profiling in Chinese colorectal cancer patients and its association with clinicopathological characteristics and prognosis - Ye - 2020 - Cancer Medicine - Wiley Online Library
Frontiers | Targeting KRAS: The Elephant in the Room of Epithelial Cancers
IJMS | Free Full-Text | Prognostic and Predictive Roles of KRAS Mutation in Colorectal Cancer
